Unknown NA INTERVENTIONAL 1-arm NCT03526705

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis Lesional Skin

Sponsor: Cairo University

Conditions Psoriasis

Interventions NB-UVB

Updated 6 times since 2018 Last updated: Jul 20, 2019 Started: Jul 15, 2019 Primary completion: Jan 15, 2020 Completion: Jan 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Psoriasis, this trial is ongoing. The trial is conducted by Cairo University and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA
Aug 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA

Phase: None → NA

▶ Show 1 earlier version

Jun 2018 — Aug 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.